Buparvet Injection


Composition:
Per ml contains
 Buparvaquone BP (Vet) 50 mg.

Description:
 Buparvaquone is a second generation hydroxynaphtaquinone used for the therapy and prophylaxis of all forms of theileriosis.

Indications:
 Theileriosis is a tick transmitted disease, caused by the intracellular protozoan parasites Theileria parva (East Coast fever, Corridor disease, Zimbabwean theileriosis) and T. annulata (tropical theilerious) in cattle.
 Buparvet is active against both the schizont and piroplasm stages of Theileria spp., and can be used during the incubation period or when clinical signs are apparent.
 Treatment with Buparvet should be given to clinically affected animals and to in-contact animals which may be infected but are not showing clinical signs.

Dosage and Administration:
 For Intramuscular Administration
General Dosage: 10 ml per 200 kg body weight.
 In severe cases the treatment may be repeated within 48 – 72 hours.
 Do not administer more than 10 ml per injection site.
 Successive injections should be administered at different sites.

Precautions:
 Buparvet should not be given by Intravenous or Subcutaneous injection.

Side Effects:
 Localised, painless, oedematous swelling may occasionally be seen at the injection site.

Withdrawal Times:
 For Meat: 42 days.
 For Milk: 2 days

Storage Conditions:
 Store below 25˚C
 Do not freeze

Packing:
 Vial of 10 ml and 50 ml.